|
KR20020064915A
(ko)
*
|
1999-11-29 |
2002-08-10 |
에이브이아이 바이오파마 인코포레이티드 |
안티센스 항박테리아 방법 및 조성물
|
|
US6784291B2
(en)
*
|
2000-05-04 |
2004-08-31 |
Avi Biopharma, Inc. |
Splice-region antisense composition and method
|
|
AU2002305941A1
(en)
*
|
2001-03-01 |
2002-09-19 |
The Johns Hopkins University |
Quantitative assay for the simultaneous detection and speciation of bacterial infections
|
|
CA2463689C
(en)
*
|
2001-10-15 |
2011-04-26 |
Nissin Food Products Co., Ltd. |
Primers and method of detecting bacteria
|
|
GB0126415D0
(en)
*
|
2001-11-02 |
2002-01-02 |
Univ Warwick |
Enzymes and enzyme inhibition
|
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
|
ATE426575T1
(de)
*
|
2003-01-07 |
2009-04-15 |
Univ Ramot |
Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
|
|
JP2004313181A
(ja)
|
2003-04-02 |
2004-11-11 |
Canon Inc |
感染症起炎菌検出用プローブ及びプローブセット、ならびに担体及び遺伝子検査方法
|
|
US7750142B2
(en)
*
|
2003-04-28 |
2010-07-06 |
Isis Pharmaceuticals, Inc. |
Modulation of glucagon receptor expression
|
|
US7399853B2
(en)
*
|
2003-04-28 |
2008-07-15 |
Isis Pharmaceuticals |
Modulation of glucagon receptor expression
|
|
CA2523672C
(en)
|
2003-04-29 |
2012-07-17 |
Avi Biopharma, Inc. |
Compositions for enhancing transport of molecules into cells
|
|
JP5137400B2
(ja)
*
|
2003-06-30 |
2013-02-06 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． |
アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法
|
|
AU2004263124B2
(en)
*
|
2003-08-07 |
2009-01-15 |
Avi Biopharma, Inc. |
Sense antiviral compound and method for treating ssRNA viral infection
|
|
US20050222068A1
(en)
*
|
2003-10-23 |
2005-10-06 |
Mourich Dan V |
Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
|
|
JP4917889B2
(ja)
*
|
2003-09-25 |
2012-04-18 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． |
アミロイド関連疾患を処置するための組成物及びその使用方法
|
|
WO2005031362A2
(en)
*
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
|
US20050171044A1
(en)
*
|
2003-12-24 |
2005-08-04 |
Stein David A. |
Oligonucleotide compound and method for treating nidovirus infections
|
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
|
EP1713332A4
(en)
|
2004-01-23 |
2010-08-18 |
Avi Biopharma Inc |
ANTISENSE OLIGOMERS AND METHOD FOR INDUCTION OF IMMUNOTHERAPY AND IMMUNOSUPPRESSION
|
|
US7402574B2
(en)
*
|
2004-03-12 |
2008-07-22 |
Avi Biopharma, Inc. |
Antisense composition and method for treating cancer
|
|
ATE510914T1
(de)
|
2004-07-02 |
2011-06-15 |
Avi Biopharma Inc |
Antisinn antibakterielle verfahren und verbindungen
|
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
|
WO2006013552A2
(en)
|
2004-08-02 |
2006-02-09 |
Ramot At Tel Aviv University Ltd. |
Articles of peptide nanostructures and method of forming the same
|
|
ATE539745T1
(de)
|
2004-08-19 |
2012-01-15 |
Univ Tel Aviv Future Tech Dev |
Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
|
|
US7786086B2
(en)
*
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
|
US8129352B2
(en)
|
2004-09-16 |
2012-03-06 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating ssRNA viral infection
|
|
US8357664B2
(en)
*
|
2004-10-26 |
2013-01-22 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating influenza viral infection
|
|
US7524829B2
(en)
*
|
2004-11-01 |
2009-04-28 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
|
AU2006213686A1
(en)
|
2005-02-09 |
2006-08-17 |
Avi Bio Pharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
|
US20060240032A1
(en)
*
|
2005-03-31 |
2006-10-26 |
Hinrichs David J |
Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases
|
|
US7300631B2
(en)
*
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
|
US20060293268A1
(en)
*
|
2005-05-05 |
2006-12-28 |
Rieder Aida E |
Antisense antiviral compounds and methods for treating foot and mouth disease
|
|
WO2006138145A1
(en)
|
2005-06-14 |
2006-12-28 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
|
US20060292575A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Asiagen Corporation |
Novel method for diagnosing pathogens of sexually transmitted diseases
|
|
US7790694B2
(en)
*
|
2005-07-13 |
2010-09-07 |
Avi Biopharma Inc. |
Antisense antibacterial method and compound
|
|
US8067571B2
(en)
*
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
US8524676B2
(en)
*
|
2005-09-08 |
2013-09-03 |
Sarepta Therapeutics, Inc. |
Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds
|
|
US8329668B2
(en)
*
|
2005-09-08 |
2012-12-11 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating picornavirus infection
|
|
JP4827483B2
(ja)
*
|
2005-10-04 |
2011-11-30 |
キヤノン株式会社 |
核酸試料処理装置
|
|
US10004828B2
(en)
*
|
2005-10-11 |
2018-06-26 |
Romat at Tel-Aviv University Ltd. |
Self-assembled Fmoc-ff hydrogels
|
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
|
US8501704B2
(en)
|
2005-11-08 |
2013-08-06 |
Sarepta Therapeutics, Inc. |
Immunosuppression compound and treatment method
|
|
CA2644262C
(en)
*
|
2006-03-07 |
2016-01-05 |
Avi Biopharma, Inc. |
Antisense antiviral compound and method for treating arenavirus infection
|
|
BRPI0710889A2
(pt)
*
|
2006-04-24 |
2011-08-16 |
Sigma Alimentos Sa De Cv |
método para a detecção e quantificação múltipla e simultánea de patogênicos mediante a reação em cadeia da polimerasa em tempo real
|
|
DK2735568T3
(da)
*
|
2006-05-10 |
2017-11-13 |
Sarepta Therapeutics Inc |
Oligonukleotidanaloger med kationiske bindinger mellem underenheder
|
|
US8785407B2
(en)
*
|
2006-05-10 |
2014-07-22 |
Sarepta Therapeutics, Inc. |
Antisense antiviral agent and method for treating ssRNA viral infection
|
|
US20070265215A1
(en)
*
|
2006-05-11 |
2007-11-15 |
Iversen Patrick L |
Antisense restenosis composition and method
|
|
WO2008064304A2
(en)
|
2006-11-22 |
2008-05-29 |
Trana Discovery, Inc. |
Compositions and methods for the identification of inhibitors of protein synthesis
|
|
US20090035767A1
(en)
*
|
2006-11-28 |
2009-02-05 |
Canon Kabushiki Kaisha |
Primer for bacterium genome amplification reaction
|
|
US20080173652A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Bob Chou |
Integral heat-resisting structure of a disposable drinking cup
|
|
US8507200B2
(en)
*
|
2007-02-09 |
2013-08-13 |
Northwestern University |
Particles for detecting intracellular targets
|
|
DK2160464T3
(da)
*
|
2007-05-30 |
2014-08-04 |
Univ Northwestern |
Nukleinsyrefunktionaliserede nanopartikler til terapeutiske anvendelser
|
|
EP1997907A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Bifidobacteria
|
|
EP2201118B1
(en)
*
|
2007-09-14 |
2012-04-18 |
Trana Discovery |
Compositions and methods for the identification of inhibitors of retroviral infection
|
|
CA2717244A1
(en)
*
|
2008-03-03 |
2009-09-11 |
Saitama Medical University |
Method of distinguishing inflammatory pathogen causing acute respiratory infection
|
|
KR100966015B1
(ko)
*
|
2008-03-24 |
2010-06-24 |
이화여자대학교 산학협력단 |
식중독 병원균의 동시 검출용 프라이머 및 이의 용도
|
|
EP2342339A4
(en)
*
|
2008-09-29 |
2012-06-06 |
Trana Discovery Inc |
SCREENING PROCEDURE FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS
|
|
CN106955360A
(zh)
|
2008-11-24 |
2017-07-18 |
西北大学 |
多价rna纳米颗粒组合物
|
|
AU2009335740B2
(en)
*
|
2008-12-17 |
2016-04-21 |
Sarepta Therapeutics, Inc. |
Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
WO2010081049A1
(en)
*
|
2009-01-08 |
2010-07-15 |
Northwestern University |
Inhibition of bacterial protein production by polyvalent oligonucleotide modified nanoparticle conjugates
|
|
EP2419535B1
(en)
|
2009-04-15 |
2022-08-17 |
Northwestern University |
Delivery of oligonucleotide-functionalized nanoparticles
|
|
CA2768768C
(en)
|
2009-06-23 |
2021-08-24 |
Gen-Probe Incorporated |
Compositions and methods for detecting nucleic acid from mollicutes
|
|
EP2816111B1
(en)
*
|
2009-08-14 |
2016-04-13 |
Epicentre Technologies Corporation |
Methods, compositions, and kits for generating rRNA-depleted samples or isolating rRNA from samples
|
|
DK2494075T3
(en)
|
2009-10-30 |
2018-07-23 |
Univ Northwestern |
TABLE-MANAGED NANOCONJUGATES
|
|
AU2010319314C1
(en)
|
2009-11-13 |
2016-09-01 |
Sarepta Therapeutics, Inc. |
Antisense antiviral compound and method for treating influenza viral infection
|
|
WO2011091065A2
(en)
|
2010-01-19 |
2011-07-28 |
Northwestern University |
Synthetic nanostructures including nucleic acids and/or other entities
|
|
US20130101512A1
(en)
|
2010-03-12 |
2013-04-25 |
Chad A. Mirkin |
Crosslinked polynucleotide structure
|
|
KR20200133284A
(ko)
|
2010-05-28 |
2020-11-26 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체
|
|
US8198429B2
(en)
|
2010-08-09 |
2012-06-12 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
|
WO2012031243A2
(en)
|
2010-09-03 |
2012-03-08 |
Avi Biopharma, Inc. |
dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
|
|
EP3067420A1
(en)
*
|
2010-11-12 |
2016-09-14 |
Sarepta Therapeutics, Inc. |
Antisense antibacterial compounds and methods
|
|
CN103298826A
(zh)
|
2010-11-15 |
2013-09-11 |
特拉维夫大学拉莫特有限公司 |
用于治疗淀粉样纤维形成相关疾病的二肽类似物
|
|
US9889209B2
(en)
|
2011-09-14 |
2018-02-13 |
Northwestern University |
Nanoconjugates able to cross the blood-brain barrier
|
|
ES2796556T3
(es)
|
2011-09-20 |
2020-11-27 |
Ionis Pharmaceuticals Inc |
Modulación antisentido de la expresión de GCGR
|
|
BR112014006527A2
(pt)
*
|
2011-09-21 |
2017-03-28 |
Syngenta Participations Ag |
resistência patogênica
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
EA202090338A1
(ru)
|
2011-11-18 |
2021-04-30 |
Сарепта Терапьютикс, Инк. |
Функционально-модифицированные олигонуклеотиды и их субъединицы
|
|
US9556439B2
(en)
|
2012-02-09 |
2017-01-31 |
Bavarian Nordic A/S |
Agonists and antagonists of toll-like receptor (TLR) 13
|
|
JP5800443B2
(ja)
*
|
2012-11-09 |
2015-10-28 |
株式会社村田製作所 |
二次電池、及び二次電池の充放電方法
|
|
CN105579582A
(zh)
|
2013-07-25 |
2016-05-11 |
埃克西奎雷股份有限公司 |
用于预防和治疗用途的作为免疫刺激剂的基于球形核酸的构建体
|
|
JP6527516B2
(ja)
|
2013-12-03 |
2019-06-05 |
ノースウェスタン ユニバーシティ |
リポソーム粒子、前述のものを作製する方法及びその使用
|
|
EP3140424B1
(en)
*
|
2014-05-06 |
2020-04-29 |
IS Diagnostics LTD |
Microbial population analysis
|
|
AU2015269412B2
(en)
|
2014-06-04 |
2020-03-12 |
Exicure Operating Company |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
WO2016028940A1
(en)
|
2014-08-19 |
2016-02-25 |
Northwestern University |
Protein/oligonucleotide core-shell nanoparticle therapeutics
|
|
CA2963931A1
(en)
|
2014-10-06 |
2016-04-14 |
Exicure, Inc. |
Anti-tnf compounds
|
|
CN108474042B
(zh)
*
|
2014-10-17 |
2022-02-11 |
弗雷德哈钦森癌症研究中心 |
一种评估幽门螺杆菌感染的试剂成分，试剂盒以及方法
|
|
KR20170078843A
(ko)
|
2014-11-21 |
2017-07-07 |
노오쓰웨스턴 유니버시티 |
구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
|
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
|
EP3302489A4
(en)
|
2015-06-04 |
2019-02-06 |
Sarepta Therapeutics, Inc. |
METHOD AND COMPOUNDS FOR THE TREATMENT OF DISEASES AND SUFFERING IN CONNECTION WITH LYMPHOCYTES
|
|
AU2016379402B2
(en)
|
2015-12-23 |
2023-01-12 |
Board Of Regents, The University Of Texas System |
Antisense antibacterial compounds and methods
|
|
KR102326351B1
(ko)
*
|
2016-05-10 |
2021-11-12 |
아메리칸 몰레큘라 래보러토리즈, 인크. |
포르말린-고정 파라핀-포매 생물학적 샘플로부터 약물 내성 박테리아를 특성화하는 방법 및 조성물
|
|
JP2020526558A
(ja)
|
2017-07-13 |
2020-08-31 |
ノースウェスタン ユニバーシティ |
オリゴヌクレオチド官能化金属有機構造体ナノ粒子を調製するための一般的かつ直接的な方法
|
|
JP2020530493A
(ja)
*
|
2017-08-07 |
2020-10-22 |
フィンチ セラピューティクス、インコーポレイテッド． |
腸内の抗生物質耐性菌を除菌するための組成物及び方法
|
|
WO2019142190A1
(en)
*
|
2018-01-17 |
2019-07-25 |
Augmanity Nano Ltd. |
A set of anti-pathogenic nucleic acids, compositions and uses thereof
|
|
US12233168B2
(en)
|
2019-04-08 |
2025-02-25 |
University Of Massachusetts |
Localization of payload delivery systems to tumor sites via beacon cell targeting
|
|
US12319711B2
(en)
|
2019-09-20 |
2025-06-03 |
Northwestern University |
Spherical nucleic acids with tailored and active protein coronae
|
|
US12378560B2
(en)
|
2019-10-29 |
2025-08-05 |
Northwestern University |
Sequence multiplicity within spherical nucleic acids
|